Matthew T. Howard

Dr. Matthew T. Howard is a Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine in Rochester, Minnesota. With over 15 years of experience since completing his medical training, he has established himself as a leading expert in hematopathology, particularly in the characterization of amyloidosis and myeloid/lymphoid neoplasms.

Dr. Howard's research interests focus on amyloidosis across multiple organ systems, proteomic analysis for disease characterization, and diagnostic techniques for lymphoproliferative disorders. His work bridges laboratory medicine with clinical applications, emphasizing how pathological findings correlate with patient outcomes. His research has significantly advanced the field of amyloid typing using mass spectrometry, with his 2020 Mayo Clinic Proceedings paper reviewing over 16,000 samples.

His publication record demonstrates consistent scholarly productivity with numerous high-impact papers in pathology and hematology journals. Approximately 70% of his publications involve first or senior authorship on studies related to amyloidosis characterization. His research has important clinical implications for diagnosis and treatment selection in systemic amyloid diseases.

Dr. Howard has received recognition including the 2009 Resident Teaching Award from Cleveland Clinic. His professional memberships include the College of American Pathologists and American Society for Clinical Pathology, where he has contributed to committee work related to pathology standardization and practice integration.

As Director of the HemePath/Morphology Lab since 2011, Dr. Howard oversees critical diagnostic services while maintaining an active research program. His leadership extends to multiple departmental committees where he contributes to strategic planning and operational excellence in laboratory medicine.